Deutsche Bank’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q4 | – | Sell |
-474,675
| Closed | -$35.6M | – | 5020 |
|
2015
Q3 | $35.6M | Buy |
474,675
+137,082
| +41% | +$10.3M | 0.03% | 608 |
|
2015
Q2 | $25.4M | Buy |
337,593
+77,232
| +30% | +$5.82M | 0.02% | 813 |
|
2015
Q1 | $13.1M | Buy |
260,361
+210,648
| +424% | +$10.6M | 0.01% | 1156 |
|
2014
Q4 | $1.72M | Buy |
49,713
+1,283
| +3% | +$44.5K | ﹤0.01% | 2757 |
|
2014
Q3 | $1.59M | Buy |
48,430
+37,472
| +342% | +$1.23M | ﹤0.01% | 2653 |
|
2014
Q2 | $419K | Sell |
10,958
-54,387
| -83% | -$2.08M | ﹤0.01% | 3491 |
|
2014
Q1 | $2.6M | Buy |
65,345
+17,593
| +37% | +$699K | ﹤0.01% | 2233 |
|
2013
Q4 | $1.78M | Buy |
47,752
+29,113
| +156% | +$1.09M | ﹤0.01% | 2349 |
|
2013
Q3 | $849K | Buy |
18,639
+9,088
| +95% | +$414K | ﹤0.01% | 3100 |
|
2013
Q2 | $256K | Buy |
+9,551
| New | +$256K | ﹤0.01% | 3649 |
|